Nicolas Marcoux

6PUBLICATIONS
32CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 26, 2026
Pragmatic Management of EGFR-Mutant NSCLC After Progression on Osimertinib: Canadian Expert Perspectives.

|Feb 26, 2026
Corticosteroids for Managing TRK Inhibitor Withdrawal Pain: A Report on Two Cases.

Nicolas Marcoux, Louis-Philippe Grenier

|Jan 28, 2026
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial.

Sreya Duttagupta, Meriem Messaoudene, Sebastian Hunter

|Aug 27, 2025
Pembrolizumab-Induced Simultaneous and Refractory Systemic Capillary Leak and Cytokine Release Syndromes: A Case Report.

Eugénie Roberge-Maltais, Eric Lévesque, Vincent Castonguay

|Nov 26, 2024
Esophagitis and Pneumonitis Related to Concurrent Chemoradiation ± Durvalumab Consolidation in Unresectable Stage III Non-Small-Cell Lung Cancer: Risk Assessment and Management Recommendations Based on a Modified Delphi Process.

Anthony M Brade, Houda Bahig, Andrea Bezjak

|Sep 28, 2018
Landscape of Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired RET Fusion.

Zofia Piotrowska, Hideko Isozaki, Jochen K Lennerz

Pageof 1

Frequent Collaborators

2 joint publications

Louis-Philippe Grenier

1 joint publications

Satoshi Yoda

1 joint publications

Jessica J Lin

1 joint publications

Richard B Lanman